Amyloid‐β PET and CSF in an autopsy‐confirmed cohort

OBJECTIVE: Accumulation of amyloid‐β is among the earliest changes in Alzheimer’s disease (AD). Amyloid‐β positron emission tomography (PET) and Aβ (42) in cerebrospinal fluid (CSF) both assess amyloid‐β pathology in‐vivo, but 10–20% of cases show discordant (CSF+/PET− or CSF‐/PET+) results. The neu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Reimand, Juhan, Boon, Baayla D. C., Collij, Lyduine E., Teunissen, Charlotte E., Rozemuller, Annemieke J. M., van Berckel, Bart N. M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7664271/
https://ncbi.nlm.nih.gov/pubmed/33080124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51195
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars